Align Technology, Inc. vs Merck & Company, Inc. — Stock Comparison

ALGN
Align Technology, Inc.
$178.91
▲ 1.65%
vs
MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
Q·Score Winner
Align Technology, Inc.
ALGN7.1/10vs 6.7/10

Q·Score Breakdown

7.1
Bullish
Overall
6.7
Neutral
5.7
Quality
6.2
8
Health
7
7.5
Growth
6.2
7.8
Valuation
7.2
6.9
Sentiment
7.1
ALGN

Clean balance sheet with low leverage (0.0× debt-to-equity).

MRK

Forward P/E of 11.5× is low relative to sector peers.

Analyst Consensus

BUY
Target $209.00 (+16.8%)
14 analysts
BUY
Target $129.74 (+15.7%)
27 analysts

Fundamentals

ALGN
MRK
30.0×
Trailing P/E
31.5×
14.5×
Forward P/E
11.5×
10.5%
Profit Margin
13.6%
70.5%
Gross Margin
76.6%
10.8%
ROE
6.2%
Revenue Growth
4.9%
23.9%
Earnings Growth
1.81
Beta
0.28
Price / Book
$12.8B
Market Cap
$277.0B
$122 – $208
52-Week Range
$73 – $125

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →